Antozzi Carlo, Binelli Simona, Frassoni Carolina, Ciano Claudia, Vincent Angela, Andreetta Francesca, Panzica Ferruccio, Franceschetti Silvana, Confalonieri Paolo, Mantegazza Renato
Myopathology and Immunology Unit, Neurological Institute Foundation "C Besta", Milan, Italy.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.09.2008.0988. Epub 2009 Feb 2.
Antibodies to potassium channels (VGKC-Ab) were first associated with acquired neuromyotonia and its variant with CNS involvement, Morvan's syndrome. Recently, VGKC-Ab were found in patients with non-paraneoplastic limbic encephalitis (LE), characterised by personality changes, seizures and memory impairment. These patients may respond to immunotherapies. Thus the association of VGKC-Ab and non-paraneoplastic LE established the concept of a potentially reversible autoimmune encephalopathy. We describe a patient with startle syndrome and VGKC-Ab, without neuromyotonia or LE, who responded dramatically to plasma exchange (PE) and immunosuppression, adding to the spectrum of disorders associated with VGKC-Ab.
钾通道抗体(VGKC-Ab)最初与获得性神经性肌强直及其伴有中枢神经系统受累的变异型——莫旺综合征相关。最近,在非副肿瘤性边缘叶脑炎(LE)患者中发现了VGKC-Ab,其特征为性格改变、癫痫发作和记忆障碍。这些患者可能对免疫疗法有反应。因此,VGKC-Ab与非副肿瘤性LE的关联确立了一种潜在可逆性自身免疫性脑病的概念。我们描述了一名患有惊吓综合征和VGKC-Ab的患者,该患者没有神经性肌强直或LE,对血浆置换(PE)和免疫抑制治疗反应显著,这进一步拓展了与VGKC-Ab相关的疾病谱。